 |
 |
Dear Jorge, After reading your post in regard to mirapex and it's effectiveness or (ineffectiveness) in neuroprotection, I am prompted to respond. It seems that the report of the studies done in this area have been highly promoted and would lead to a general acceptance of the effectiveness of this drug (mirapex) as a neuroprotectant. Of course, with this perception, the sales of this drug will undoubtedly increase dramatically. Since this study was carried out by the drug company which manufactures and sells the drug in question, it leads to doubts as to it's unbiased conclusions. I have read the published report on the study and the wording sounds vague and less than conclusive. I feel that it would be a travesty, if in fact it could be true, that the drug companies who are selling drugs to those who are so desperate for the glimmer of a hope could stoop to the level of promising something that is less than authentic. I take Requip now and am doing so because I was told that it will treat my symptoms and enable me to delay taking leva-dopa. I made this decision based upon my doctor's recommendation, my reliance on his informed medical opinion and the belief in his genuine concern for me that he would advise the best treatment possible for my disorder. To think that drug companies would perform otherwise just to boost their sales to become even richer is not acceptable. Now the question is: how is the legitimacy of this finding proved or disproved. Dee ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn